R&D Delays, Mismatch with Market Needs, and Failure to Commercialize
First written in FY2016. 4 of 5 entries say "Restated". Latest entry: FY2021.
The whole theme swung hardest in 2026: 14 of 29 companies on the "Worse" side.
74 other companies' latest entry also says "Restated".
- FY2021RestatedAnnual report
「In response, we are working to reduce these risks across a diverse range of markets by identifying customer needs through close relationships with customers, differentiating ourselves through the development of original products that leverage our proprietary technologies, and actively collaborating with universities and research institutions.」
In response to risks including delays in research and development and mismatches with market needs, the company continues to identify customer needs, conduct proprietary development, and collaborate with universities and research institutions. - FY2019RestatedAnnual report
「Because this research and development requires substantial expenditure and time, failure to proceed as planned could result in the loss of opportunities to commercialise products, a mismatch with market needs could prevent products from reaching the market, or products could fail to deliver sufficient results even after commercialisation, any of which could affect the performance and financial position of our group.」
The risks associated with research and development costs and time, delays in the plan, mismatches with market needs, and insufficient results after commercialisation continue to be identified. - FY2018RestatedAnnual report
「Because this research and development requires substantial expenditure and time, failure to proceed as planned could result in the loss of opportunities to commercialise products, a mismatch with market needs could prevent products from reaching the market, or products could fail to deliver sufficient results even after commercialisation, any of which could affect the performance of our group.」
The risks associated with research and development costs and time, delays in the plan, mismatches with market needs, and insufficient results after commercialisation continue to be identified. - FY2017RestatedAnnual report
「Because this research and development requires substantial expenditure and time, failure to proceed as planned could result in the loss of opportunities to commercialise products, a mismatch with market needs could prevent products from reaching the market, or products could fail to deliver sufficient results even after commercialisation, any of which could affect the performance of our group.」
The risks associated with research and development costs and time, delays in the plan, mismatches with market needs, and insufficient results after commercialisation continue to be identified. - FY2016First statedAnnual report
「Because this research and development requires substantial expenditure and time, failure to proceed as planned could result in the loss of opportunities to commercialise products, a mismatch with market needs could prevent products from reaching the market, or products could fail to deliver sufficient results even after commercialisation, any of which could adversely affect the performance of our group.」
The costs and time required for research and development, as well as delays, mismatches with market needs, and insufficient results after commercialisation, are identified as risks.